First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders
Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.
This is the notice a psychiatric drug or device company should read first. It funds the step into people, for both modalities, under one announcement.
What qualifies is novelty of mechanism. Investigational drugs with a novel mechanism of action, or novel neuromodulatory devices, for psychiatric disorders in areas of unmet medical need. Paediatric and adult populations are both in scope, and the …
Milestone-driven early-stage clinical trials of novel mechanism of action investigational drugs and novel neuromodulatory devices for psychiatric disorders in areas of unmet medical need, in paediatric and adult populations — first-in-human and phase II drug studies assessing target engagement, pharmacological effects, safety and tolerability; proof-of-concept studies evaluating functional and clinical measures; and first-in-human and early feasibility device studies. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
More from NIH
All grants from this funder →Advanced Development of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the enhancement of a cancer informatics tool that has cleared prototyping, shows real promise, and has not yet been widely adopted.
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All
🇺🇸NIH · United States
Funds a single hub that coordinates data, evaluation and operations for a consortium of community-based oral health research projects.
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03)
🇺🇸NIH · United States
Funds one small self-contained project for a scholar already inside the Clinical and Translational Science Award network, on the way to a first full award.
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)
NIH · United States
Funds the move of an imaging-centred multimodal AI tool from a trained and tested prototype towards real clinical use, as regulated device software.
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data
NIH · United States
Funds a company and an academic team to build and test an imaging-centred multimodal AI decision tool, developed as software that is a medical device.
Sustained Support for Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the running costs and continued relevance of a cancer informatics tool that researchers already depend on.
Similar grants
Browse the directory →
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.
ARPA-H Initiatives & Sprints
🇺🇸ARPA-H · United States
Runs fast-turnaround health technology opportunities in United States for high-potential exploratory science and engineering.
ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
NIH Common Fund Venture Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.
Defense Health Agency SBIR Phase I
🇺🇸DHA · United States
Funds United States defense medical innovators at feasibility stage for life-changing military health technologies.
Defense Health Agency SBIR Phase II
🇺🇸DHA · United States
Supports United States defense health teams maturing validated medical technologies toward practical military use.